By Regulatory Approvals — FDA Approves Rusfertide for Polycythemia Vera Targeted Oncology
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 31, 2026.